February 2024 Price Concessions Final Update
THIS CONTENT HAS NOW EXPIRED
Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (29/02/2024) announced the following final list of price concessions for February 2024.
Drug | Pack size | Price concession |
Aripiprazole 10mg tablets | 28 | £9.53 |
Aripiprazole 15mg tablets | 28 | £9.69 |
Aripiprazole 5mg tablets | 28 | £7.57 |
Baclofen 10mg tablets | 84 | £2.78 |
Baclofen 5mg/5ml oral solution sugar free | 300 | £3.46 |
Benzoyl peroxide 5% / Clindamycin 1% gel | 30 | £12.07 |
Benzylpenicillin 600mg powder for solution for injection vials | 2 | £6.01 |
Betamethasone valerate 0.1% cream | 30 | £1.43 |
Bimatoprost 100micrograms/ml eye drops | 3 | £4.60 |
Bisacodyl 5mg gastro-resistant tablets | 60 | £4.25 |
Cabergoline 500microgram tablets | 8 | £17.52 |
Calcium and Ergocalciferol tablets | 28 | £52.70 |
Cefalexin 500mg capsules | 21 | £2.64 |
Cinacalcet 30mg tablets | 28 | £8.72 |
Clarithromycin 125mg/5ml oral suspension | 70 | £3.87 |
Clarithromycin 250mg tablets | 14 | £2.88 |
Clarithromycin 250mg/5ml oral suspension | 70 | £5.50 |
Clobazam 10mg tablets | 30 | £4.99 |
Clonidine 25microgram tablets | 112 | £15.98 |
Co-amoxiclav 250mg/125mg tablets | 21 | £3.51 |
Co-careldopa 12.5mg/50mg tablets | 90 | £4.59 |
Co-careldopa 25mg/100mg tablets | 100 | £8.90 |
Cyclizine 50mg tablets | 100 | £3.99 |
Digoxin 125microgram tablets | 28 | £2.90 |
Digoxin 250microgram tablets | 28 | £2.56 |
Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops | 5 | £4.20 |
Dorzolamide 20mg/ml eye drops | 5 | £3.12 |
Duloxetine 20mg gastro-resistant capsules | 28 | £8.40 |
Etoricoxib 30mg tablets | 28 | £4.02 |
Etoricoxib 60mg tablets | 28 | £15.14 |
Etoricoxib 90mg tablets | 28 | £12.52 |
Famotidine 40mg tablets | 28 | £28.51 |
Fenofibrate micronised 160mg tablets | 28 | £3.29 |
Hydrocortisone 1% cream | 15 | £2.49 |
Hydrocortisone 1% cream | 30 | £5.75 |
Hydroxocobalamin 1mg/1ml solution for injection ampoules | 5 | £11.14 |
Itraconazole 100mg capsules | 15 | £15.40 |
Latanoprost 50micrograms/ml / Timolol 5mg/ml eye drops | 2.5 | £7.48 |
Lofepramine 70mg tablets | 56 | £16.96 |
Lofepramine 70mg/5ml oral suspension sugar free | 150 | £147.67 |
Lorazepam 500microgram tablets | 28 | £19.57 |
Melatonin 1mg/ml oral solution sugar free | 150 | £122.86 |
Memantine 10mg tablets | 28 | £1.19 |
Mercaptopurine 50mg tablets | 25 | £8.62 |
Methenamine hippurate 1g tablets | 60 | £16.81 |
Metoclopramide 10mg tablets | 28 | £1.47 |
Metoprolol 100mg tablets | 28 | £2.75 |
Midazolam 10mg/2ml solution for injection ampoules | 10 | £5.71 |
Mometasone 0.1% cream | 30 | £3.60 |
Mometasone 0.1% ointment | 30 | £3.55 |
Mometasone 50micrograms/dose nasal spray | 140 | £4.60 |
Mycophenolate mofetil 500mg tablets | 50 | £6.19 |
Nebivolol 5mg tablets | 28 | £5.84 |
Ondansetron 4mg tablets | 10 | £5.80 |
Permethrin 5% cream | 30 | £14.78 |
Prednisolone 5mg soluble tablets | 30 | £51.51 |
Pregabalin 200mg capsules | 84 | £4.12 |
Pregabalin 300mg capsules | 56 | £3.08 |
Primidone 250mg tablets | 100 | £86.95 |
Promethazine hydrochloride 10mg tablets | 56 | £13.46 |
Propantheline bromide 15mg tablets | 112 | £108.44 |
Pyridostigmine bromide 60mg tablets | 200 | £22.27 |
Quinine sulfate 200mg tablets | 28 | £7.65 |
Rizatriptan 10mg orodispersible tablets sugar free | 3 | £8.87 |
Ropinirole 1mg tablets | 84 | £32.83 |
Ropinirole 2mg tablets | 28 | £28.19 |
Sodium chloride 0.9% nebuliser liquid 2.5ml unit dose ampoules | 20 | £9.50 |
Sodium valproate 200mg/5ml oral solution sugar free | 300 | £7.78 |
Sulpiride 200mg/5ml oral solution sugar free | 150 | £99.05 |
Tacrolimus 0.1% ointment | 30 | £15.59 |
Tacrolimus 0.1% ointment | 60 | £31.17 |
Tamsulosin 400microgram / Dutasteride 500microgram capsules | 30 | £14.83 |
Trospium chloride 20mg tablets | 60 | £10.89 |
Zolmitriptan 5mg orodispersible tablets sugar free | 6 | £23.86 |
Zonisamide 100mg capsules | 56 | £18.88 |
No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.
We encourage pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.
Please subscribe to our mailing list to receive email updates of any price concessions.
Further information on price concessions and FAQs about the process involved can be found on our website (cpe.org.uk/priceconcessions) To hear more on how the current price concessions system operates, pharmacy teams can now access a recording of our recent Medicines Supply and Concessions Briefing webinar here.
Improvements to the price concession system
Following significant concerns raised by pharmacies about the unsustainable level of prices imposed by DHSC in second half of 2022, it was agreed that an urgent review of the price concession setting system would take place.
Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system.
One of the solutions agreed between us and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.
Furthermore, from May 2023, DHSC has implemented a process to roll over prices to the following month for any concessions requested after the 23rd of the month provided these prices were agreed with us. We are also continuing to work with DHSC on how a ‘retrospective increased payment’ may apply, where appropriate. Further information regarding this concession ‘top-up’ mechanism will be issued once details are finalised.